Revised spectrum of mutations in sarcoglycanopathies
- 20 February 2008
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 16 (7), 793-803
- https://doi.org/10.1038/ejhg.2008.9
Abstract
To define the spectrum of mutations in alpha-, beta-, gamma-, and delta-sarcoglycan (SG) genes, we analyzed these genes in 69 probands with clinical and biological criteria compatible with the diagnosis of autosomal recessive limb-girdle muscular dystrophy. For 48 patients, muscle biopsies were available and multiplex western blot analysis of muscle proteins showed significant abnormalities of alpha- and gamma-SG. Our diagnostic strategy includes multiplex western blot, sequencing of SG genes, multiplex quantitative-fluorescent PCR and RT-PCR analyses. Mutations were detected in 57 patients and homozygous or compound heterozygous mutations were identified in 75% (36/48) of the patients with abnormal western blot, and in 52% (11/21) of the patients without muscle biopsy. Involvement of alpha-SG was demonstrated in 55.3% of cases (26/47), whereas gamma- and beta-SG were implicated in 25.5% (12/47) and in 17% (8/47) of cases, respectively. Interestingly, we identified 25 novel mutations, and a significant proportion of these mutations correspond to deletions (identified in 14 patients) of complete exon(s) of alpha- or gamma-SG genes, and partial duplications (identified in 5 patients) of exon 1 of beta-SG gene. This study highlights the high frequency of exonic deletions of alpha- and gamma-SG genes, as well as the presence of a hotspot of duplications affecting exon 1 of the beta-SG gene. In addition, protein analysis by multiplex western blot in combination with mutation screening and genotyping results allowed to propose a comprehensive and efficient diagnostic strategy and strongly suggested the implication of additional genes, yet to be identified, in sarcoglycanopathy-like disorders.This publication has 38 references indexed in Scilit:
- Novel sarcoglycan gene mutations in a large cohort of Italian patientsJournal of Medical Genetics, 2003
- Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutationsJournal of Medical Genetics, 2003
- Primary γ-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profileNeuromuscular Disorders, 2002
- Evaluation of cardiac and respiratory involvement in sarcoglycanopathiesNeuromuscular Disorders, 2001
- Severe γ-sarcoglycanopathy caused by a novel missense mutation and a large deletionNeuromuscular Disorders, 2000
- DEHYDROEPIANDROSTERONE RESTORES IMMUNE FUNCTION FOLLOWING TRAUMA-HAEMORRHAGE BY A DIRECT EFFECT ON T LYMPHOCYTESCytokine, 1999
- Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complexNeuromuscular Disorders, 1996
- Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophiesNeuromuscular Disorders, 1996
- β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complexNature Genetics, 1995
- Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophyCell, 1994